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ABSTRACT 
Objective: The rats were randomly divided into 5 groups and each group consisted of 6 rats and the duration of treatment was 45 days.  Body 
weight, fasting plasma glucose levels, SGOT, SGPT and ALP levels were measured.  
Methods: Albino Wistar male rats; 10- weeks old with a bodyweight ranged between 180-250 g were used. Anti-diabetic effect of plant Costus 
spicatus. In rhizome extract of ethanol extract. 
Result: The present study clearly indicates in the form of administration of C. spicatus rhizome extract towards glucose fed mice normalizes 
blood glucose level. Recent studies have revealed induced diabetic rats caused anti-diabetic effects. Histopathological studies of Pancreasin 
diabetic and treated groups are determined to show the protective action of the ECS. The administration of STZ resulted in a significant increase 
in plasma glucose level, SGOT, SGPT and ALP along with a reduction in body weight.  
Conclusion: All these effects were observed on 45th day. ECS and Glibenclamide of STZ induced diabetic animals restored the normal plasma 
glucose levels and SGOT, SGPT and ALP levels without damaging the pancreas.  
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INTRODUCTION 
Diabetes mellitus (DM) is one of the most important and 
largest epidemics public health challenges of the twenty-first 
century worldwide. DM, more simply called diabetes, is a 
chronic condition that occurs when there are raised levels of 
glucose in the blood because the body cannot produce any or 
enough of the hormone insulin or use insulin effectively. It is 
a metabolic disorder of multiple etiologies distinguished by a 
failure of glucose homeostasis with disturbances of 
carbohydrate, fat and protein metabolism as a result of 
defects in insulin secretion and/or insulin action 1. The 
family of steroid hormone receptors, a major group of the 
nuclear receptor superfamily, includes proteins that bind 
hormones, hormone response elements and a variable 
number of coactivators or corepressors with a relatively high 
degree of specificity. As regulatory components of endocrine 
activities, steroid receptors are essential for maintaining 
biological function in eukaryotic organisms, including fetal 
development, postnatal growth, and normal physiological 
function. 2-3. Non-Insulin-Dependent Diabetes Mellitus 
(NIDDM), otherwise known as type 2 diabetes (T2D), is a 
metabolic disorder characterized by insulin resistance, 
hyperglycemia and hyperinsulinemia, leading to chronic 
complications such as neuropathy, nephropathy, retinopathy 
and premature atherosclerosis 4-5. Long-standing T2DM can 
affect the vascular system leading to microvascular 
complications. The pathologic landmark of T2DM is 
microvascular complications, including nephropathy, 
retinopathy, neuropathy and microangiopathic 
cardiovascular disease (CVD). Interestingly, several studies 
report that tight glycemic control doesn't lower the incidence 
and progression of microvascular complications.Thus, 
presence of long-standing hyperglycemia doesn't explain 
microvascular complications in T2DM, and other factors 
would be contributing to the pathogenesis of such 
complications; identification of these factors should 
minimize the incidenceof these complications and improve 
their management 6. Despitetheopening of the 
hypoglycemicagentbecause of natural and synthetic sources. 
Many in the Indian medicinalplants have been useful to 
successfully manage diabetesmellitus. One of the great 
advantages ofmedicinal plants are readily available and 
contain very low side effects. Theplantssource of drugs and 
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many currently available drugs have been derived directlyor 
indirectly from them. The ethnobotanical information 
reports about 800 plants species that may possess anti-
diabetic plants potential 7. The present study is conducted to 
investigate the antidiabetic compounds, the 
antidiabeticandhypolipidemic effect of C. spicatus ethanol 
rhizome extract in (STZ)-induced diabetic male albino rats.  
MATERIALS AND METHODS 
Animal 
Albino Wistar male rats; 10- weeks old with a bodyweight 
ranged between 180-250 g were used. Animals were housed 
under standard conditions temperature (24±2°C) and 
relative humidity (30-70%) with a 12:12 (light: dark) 
conditions. The animals were fed with standard pellet diet. 
Animals were handled according to Good Laboratory 
Practice. Ethical clearance was obtained from theCommittee 
for the Purpose of Control and Supervision of experiments on 
Animal (CPCSEA). Institutional Animal EthicsCommittee 
(IAEC) RegNo:685/PO/Re/S/2002/) 
KMCRET/Ph.D/22/2018-19). 
Collection, Identification and Authentication of plant 
species:  
The plant, Costus spicatus were collected from the 
Saliyamangalam and Thanjavur district, Tamilnadu, India. It 
was taxonomically identified and authenticated by Rev Dr S. 
John Britto SJ, Director, The Rapinat Herbarium and Centre 
for Molecular Systematics, St. Joseph's College 
(Autonomous), Tiruchirappalli, Tamilnadu, India. The 
voucher specimens are deposited at the Rapinat herbarium 
and the voucher number is SAM 001. 
Plant extraction  
 Rhizome was cut into small pieces and shade dried at room 
temperature. The dried rhizome was subjected to size 
reduction to a coarse powder by using the dry grinder and 
sieved. About 100 g was continuously extracted with ethanol 
(95%) using Soxhlet extractor up to 48 h. The extract was 
filtered through Whatman filter paper and concentrated 
using rotary evaporator at 40-60ºC under reduced pressure 
to prepare the final crude extract (1g) weight. 
Diabetes induction using Streptozotocin 
Animals fasted overnight and diabetes was induced by single 
intraperitoneal injection of STZ (45mg/kg body weight) 
prepared in 0.1 M Citrate buffer at pH 4.5. To overcome drug-
induced hypoglycemia, animals were allowed to drink a 5% 
glucose solution overnight. Citrate buffer in place of 
Streptozotocin was injected to control rats. After 72 hours of 
STZ injection, (taken as 0th day) fasting blood glucose levels 
of each animal was analyzed. Animals with fasting blood 
glucose levels > 200 mg/dl were considered diabetic and 
considered for the study. 
Anti-diabetic treatment of animals  
The rats were randomly divided into 5 groups and each 
group consisted of 6 rats and the duration of treatment was 
45 days. Group I: Animals fed with distilled water (negative 
control). Group II: Diabetic animals fed with distilled water 
(positive control). Group III: Diabetic animals fed with 
Glibenclamide (5mg/kg/b.w./day). Group IV:Diabetic 
animals fed with ECS (300 mg/ kgb.w./day). Group V: 
Diabetic animals fed with ECS (500mg/kg/b.w./day). Before 
(0th), during (21st) and at the end of treatment (45th), body 
weight, fasting plasma glucose levels, SGOT,SGPT and ALP 
levels were measured. Plasma glucose levels were 
determined by Ortho Toluidine reagent method. SGOT, SGPT 
and ALP levels were measured from serum separated from 
the blood which was collected from the retro-orbital 
plexuses of the rats of all groups under light ether 
anaesthesia using a semiautomatic biochemical analyzer 
with commercially available biochemical kits. 
Collection of tissue samples and histological analysis  
After 45 days of treatment, animals were sacrificed following 
the guidelines of the animal ethical committee. The Pancreas 
tissues were excised and fixed in 10% neutral buffered 
formalin (NBF). Thus fixed Pancreastissues were sectioned 
with Leica rotary microtome to produce serial sections of 
5μm thickness. Pancreassections were stained with 
Hematoxylin and Eosin (H&E) stains. The stained specimens 
were then analyzed and photomicrographed with APCAM-5 
USB 2digital camera attached to a computer monitor 
(ADELTAVISION OPTEC India microscope Ltd). 
Statistical Analysis 
One-way analysis of variance (ANOVA) was performed using 
the software “GraphpadInstat”. Results were expressed as 
mean ± SEM. p<0.05 was considered as statistically 
significant. 
RESULTS 
Hyperglycaemia is an independent risk factor in the 
development of chronic diabetic complications. Their 
management of type 2 diabetes relies on the maintenance of 
blood glucose concentration in a normalor near-normal level. 
In Southeast Asia, it is used to treat boils, constipation, 
diarrhoea, dizziness, headache, ear, eye, and nose pain, and 
to stop vomiting. Japanese used the rhizome extract in 
control of syphilis 8. The present study clearly indicates in 
the form of administration of C. spicatus rhizome extract 
towards glucose fed mice normalizes blood glucose level. 
Recent studies have revealed induced diabetic rats caused 
anti-diabetic effects. Histopathological studies of Pancreasin 
diabetic and treated groups are determined to show the 
protective action of the ECS.The administration of STZ 
resulted in a significant increase in plasma glucose level, 
SGOT, SGPT and ALP along with a reduction in body weight 
(Table 1, 2 & 3). After treatment of animals with 500 mg/kg/ 
b.w of ECS, the plasma glucose levels significantly reduced 
and returned to normalcy (p<0.001), with a simultaneous 
increase in body weight (Table 1 & 2). 
 
Table 1:Effect of ECS on body weight in normal & STZ induced diabetic rats 
Groups Change in Bodyweight (gm) 
 0 day 21st day 45 stday 
Group I 161±2.58 85.66±2.41 196.16±2.98 
Group II 181.66±2.13** 161.83±1.47** 125.33±1.96** 
Group III 171.33±2.15# 168.33±2.44** 188.16±1.97** 
Group IV 175.16±1.60 185.50±2.14** 178.66±1.60** 
Group V 191±2.78# 181.66±2.21** 184.50±1.45** 
Results are expressed as mean ±SEM; n=6; **=p<0.001 and# =not significant 
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Table 2: Effect of ECS on plasma glucose values in normal & experimental rats 
Groups Change in Bodyweight (gm) 
 0 day 21st day 45 day 
Group I 97.16±2.12 96.33±1.76 95.5±2.12 
Group II 277.33±8.80** 337±11.07** 378.83±11.85** 
Group III 264.66±8.53# 196±7.10** 121.5±2.95** 
Group IV 268.70±0.76 102.5±1.47** 97.16±0.70** 
Group V 265.50±7.02# 98.5±10.67** 91.5±2.39** 
Results are expressed as mean ±SEM;n=6; **=p<0.001 and # =not significant 
Table 3: Effect of ECS on SGOT, SGPT and ALP levels in normal & experimental rats 
Groups SGOT (IU/L) SGPT (IU/L) ALP (IU/L) 
0 day 45 th day 0 day 45 th day 0 day 45 th day 
Group I 63.01±3.40 61.58±1.43 75.33±0.66 76±1.34 76±1.24 78.33±0.82 
Group II  153.45±2.64** 223±3.50* 247.87±2.05** 145.57±6.67** 141.68±1.57** 207±1.17** 
Group III 141.37±1.67# 101±1.28** 95.86±1.07** 143.33±1.89# 145.33±1.78# 93.4±1.53 
Group IV 132.15±0.65 158.33±0.63** 125.89±55.3** 128.85±0.08 121.87±0.70 110.3±0.99** 
Group V 109.37±3.77# 86±1.94# 107±2.17** 74.66±2.37# 127.60±2.34# 80.17±0.85** 
Results are expressed as mean ± SEM; n=6; ** =p<0.001 and # = not significant 
 
Cv-Central Vein; Vc-Vacuolation; Fc-Fatty Changes; H-Hepatocyte; S-Sinusoids 
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Figure 1A: Photomicrograph of Pancreas of normal control 
rat shows clear central vein, well-arranged hepatocytes and 
sinusoids. (H & E magnification X100)   
Figure 1B: Photomicrograph of Pancreas of STZ induced 
diabetic rat shows congested central vein, fatty degeneration 
and cytoplasmic vacuolation. (H & E magnification X100) 
Figure 1C: Photomicrograph of Pancreas of diabetic rat 
treated with Glibenclamide (5 mg/kg b.w) shows restoration 
of hepatocytes structure, clear sinusoids and reduction in 
fatty degeneration. (H & E magnification X100). 
Figure 1D: Photomicrograph of Pancreas of diabetic rats 
treated with ECS (300 mg/kg b.w) shows well-arranged 
hepatocytes in between sinusoids, with a clear central vein. 
(H & E magnification X100)   
Figure 1E: Photomicrograph of Pancreas of diabetic rat 
treated with ECS (500 mg/kg b.w.) shows restoration of 
hepatocytes structure to near normal, still little congestion 
of central vein seen. (H & E magnification X100) 
The elevated SGOT, SGPT, ALP levels in STZ induced diabetic 
animals were significantly reduced (p<0.001) in comparison 
with diabetic control (positive control) and Glibenclamide 
treated groups (Table 3). Meanwhile diabetic animals (group 
IV) treated with ECS 300 mg/kg b.w. showed no 
disturbances in the levels of plasma glucose, SGOT, SGPT, 
ALP in comparison with negative controls. 
Further histopathological examination of pancreassections 
of STZ diabetic rats showed marked hepatocyte necrosis, 
fatty degeneration,extensive vacuolization and distorted  
structure.Treatment with ECS restored the normal 
architecture of pancreas tissue in STZ diabetic rats, thereby 
proving its hepatoprotective role. No changes were found in 
the pancreas histopathology of normal rats treated with ECS, 
indicating its non-toxic nature. Treatment with 
glibenclamide also restored the mere normal architecture of 
pancreas tissue in STZ diabetic rats, but showed the 
presence of vascular congestion of the central vein and few 
hepatocyte nuclei vacuolization. These histopathological 
changes obtained in our study were indicating ECS is having 
act as an antidiabetic potential role. 
DISCUSSION 
In our study, diabetes was induced in rats by a single 
intraperitoneal injection of STZ at a dose of 45mg/kgb.w. 
and the anti-diabetic activity of ECS and its effect on 
pancreas histology functionof study. DM is associated with 
progressive metabolic derangement, worsening glycemic 
control and morphological changes in the liver, pancreas and 
other organs 9-10. The elevated levels of SGOT, SGPT in serum 
are an indication of damaged Pancreastissue, administration 
of ECS improves the Pancreasfunction by decreasing the 
levels of SGOT, SGPT in diabetic treated rats, indicating its 
hepatoprotective effect. ALP acts as a marker for biliary 
function 11. In thestudy, diabetes was induced in rats by 
single intraperitoneal injection of STZ at a dose of 45 mg/kg 
b.w. and the histological basis of hepatoprotective activity of 
ACD 500 mg/kg b.w. was determined. Diabetes mellitus is 
associated with progressive metabolic derangement, 
worsening glycemic control, and morphological changes in 
the liver, pancreas and other organs 9,12. The blood glucose 
level in alloxan induced diabetic rats by an ethanolic extract 
due to decrease abdominal glucose absorption and recover 
extra pancreatic activity including the invigoration of 
peripheral glucose utilization or incitement of glycolytic 
glucose utilization process with conterminous decrease in 
glyconeogenis 13. 
Liver productionsof important role in the monitoring and 
stabilizing glucose level so shecouldremain considered 
glucostat monitor. The results showed that injection of 
alloxan induces a hepatocellular damage, which remains 
indicated by a significant increase in AST, ALT and ALP in 
the diabetic group as compared to control groups. Elevated 
level showed that AST, ALT and ALP impaired liver function 
14. STZ-induced diabetes is characterized inaunembellished 
loss of body weight. Glibenclamide is regularly used as a 
standard antidiabetic drug in STZ-induced moderate 
diabetes to be compared with a variety of hypoglycemic 
compounds and its efficiency is recognized 15-16. The 
elevation of liver biomarker enzymes, such as AST, ALT and 
ALP in diabetic control rats  indicates that diabetes may 
induce hepatic dysfunction 17. That liver was necrotized in 
diabetic patients. Therefore, the increment of the activities 
of AST, ALT and ALP in serum may be mainly due to the 
leakage of these enzymes after the liver cytosol into the 
blood stream 18. Antidiabetic medicinal plants, despite the 
vast amount ofprogress, witnessed thus far, it is clear that 
further studiesare required to clarify the potential anti-
diabetic effectsof natural products. 
CONCLUSION 
Costus spicatus beneficial effects as both antidiabetic, 
antihyperglycemic agents and also warrants further 
studiesto isolate and characterize potent molecules for DM 
and its lipidsassociated complications. All these effects were 
observed on 45th day. The present experimental results 
indicated that ethanol extracts of Costus spicatus exhibited a 
potent Anti-hyperlipidaemic activity property in STZ 
induced diabetic rats. ECS and Glibenclamide of STZ induced 
diabetic animals restored the normal plasma glucose levels 
and SGOT, SGPT and ALP levels without damaging the 
pancreas. 
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